An artificial intelligence algorithm accurately detected one-quarter of interval cancers on screening mammograms and accurately located three-quarters of them, which could result in earlier detection of breast cancer.
The analysis of mammograms using artificial intelligence (AI) has shown great potential for assisting breast cancer screening. We use saliency maps to study the role of breast lesions in the decision-making process of AI systems for breast cancer detection in screening mammograms. We retrospectively collected mammograms from 191 women with screen-detected breast cancer and 191 healthy controls matched by age and mammographic system. Two radiologists manually segmented the breast lesions in the mammograms from CC and MLO views. We estimated the detection performance of four deep learning-based AI systems using the area under the ROC curve (AUC) with a 95% confidence interval (CI). We used automatic thresholding on saliency maps from the AI systems to identify the areas of interest on the mammograms. Finally, we measured the overlap between these areas of interest and the segmented breast lesions using Dice’s similarity coefficient (DSC). The detection performance of the AI systems ranged from low to moderate (AUCs from 0.525 to 0.694). The overlap between the areas of interest and the breast lesions was low for all the studied methods (median DSC from 4.2% to 38.0%). The AI system with the highest cancer detection performance (AUC = 0.694, CI 0.662–0.726) showed the lowest overlap (DSC = 4.2%) with breast lesions. The areas of interest found by saliency analysis of the AI systems showed poor overlap with breast lesions. These results suggest that AI systems with the highest performance do not solely rely on localized breast lesions for their decision-making in cancer detection; rather, they incorporate information from large image regions. This work contributes to the understanding of the role of breast lesions in cancer detection using AI.
Remote continuous patient monitoring is an essential feature of eHealth systems, offering opportunities for personalized care. Among its emerging applications, emotion and stress recognition hold significant promise, but face major challenges due to the subjective nature of emotions and the complexity of collecting and interpreting related data. This paper presents a review of open access multimodal datasets used in emotion and stress detection. It focuses on dataset characteristics, acquisition methods, and classification challenges, with attention to physiological signals captured by wearable devices, as well as advanced processing methods of these data. The findings show notable advances in data collection and algorithm development, but limitations remain, e.g., variability in real-world conditions, individual differences in emotional responses, and difficulties in objectively validating emotional states. The inclusion of self-reported and contextual data can enhance model performance, yet lacks consistency and reliability. Further barriers include privacy concerns, annotation of long-term data, and ensuring robustness in uncontrolled environments. By analyzing the current landscape and highlighting key gaps, this study contributes a foundation for future work in emotion recognition. Progress in the field will require privacy-preserving data strategies and interdisciplinary collaboration to develop reliable, scalable systems. These advances can enable broader adoption of emotion-aware technologies in eHealth and beyond.
(2020). Immune checkpoint inhibitor-induced myocarditis not visible with cardiac magnetic resonance imaging but detected with PET-CT: a case report. Acta Oncologica. Ahead of Print.
Histopathological investigation of metastasis in core needle axillary lymph node (ALN) biopsies is crucial for the prognosis and treatment planning of breast cancer patients. Biopsies are typically sliced and evaluated as two-dimensional (2D) images. Biopsy sampling errors and the limited view provided by 2D histology are leading factors contributing to false-negative results in the preoperative detection of metastatic lymph nodes and underestimation of metastatic foci. In this proof-of-concept study, we aim to explore the technical feasibility and the potential capacities of tridimensional (3D) X-ray micro-computed tomography imaging to expedite error detection, enhancement of histopathological accuracy, and precise measurement of metastatic lesion on ALN core needle biopsies of two breast cancer patients. Our self-developed micro-CT protocol uses eosin for the first time, a common histological dye, to enhance 3D architecture of ALNs. Performed analysis on the images of the ALN biopsies involves cancer tissue segmentation, swift biopsy evaluation, and measurement of the metastatic longest diameter and deposit volume. The eosin micro-CT protocol shows potential for an improved tumor deposit estimates, offering additional clinical value compared to standard 2D histology, however, further studies for validating this method are needed.